$569.00
In Stock
Litak or Leukladin is prescribed for the treatment of hairy cell leukemia.
Indicated as a second-line drug for the treatment of patients diagnosed with recurrent or treatment-resistant low-grade lymphoproliferative diseases, such as follicular and diffuse non-Hodgkin lymphoma, chronic lymphocytic leukemia, Waldenström macroglobulinemia.
Active ingredient: Cladribine
Prescription drug
Storage temperature 2-8 degrees
